Is Marijuana Good for Back Pain? What the Science Says

Cannabis shows real promise for chronic back pain, but the evidence is weaker and more complicated than many people assume. Multiple systematic reviews have found that most studies point toward some pain reduction, yet the highest-quality trials produce the smallest effects, and at least one well-designed placebo-controlled study of CBD for acute low back pain found no benefit at all. The picture changes depending on what kind of cannabis product you use, whether your pain is acute or chronic, and whether you are trying to manage pain on its own or reduce your reliance on opioids. The science is evolving fast, and some of the most encouraging results have emerged only in the last couple of years.

What the Clinical Evidence Actually Shows

Several systematic reviews have tried to pull together what we know about cannabis and back pain, and they arrive at a similar place: there are signals of benefit, but the evidence base is thin. One review in Global Spine Journal examined studies of cannabis for spinal pain and found that in three out of four included studies, the cannabinoid group experienced a statistically significant reduction in pain compared to controls. Pain scores improved after three and six months of follow-up. But the review also noted high dropout rates, small sample sizes, and an inability to recommend cannabis as a routine alternative to opioids based on the current level of evidence.¹

A second systematic review, published in Current Pain and Headache Reports, echoed those findings. Observational studies and lower-quality designs generally showed decreases in low back pain or opioid use over time. However, the one randomized controlled trial included in that review found no statistically significant difference between cannabis and placebo groups. The authors concluded there is minimal high-quality evidence to support medical cannabis as a first-line treatment for low back pain.²

A pattern runs through this research: when patients know they are getting cannabis (as in open-label and observational studies), they tend to report meaningful improvement. When the study is blinded and controlled, the effect shrinks considerably. This does not mean the benefit is imaginary, but it does mean you should be cautious about dramatic claims.

The Placebo Problem in Cannabis Pain Research

One of the most important wrinkles in this field is the outsized role of placebo. A meta-analysis in JAMA Network Open found that pain intensity dropped significantly in response to placebo across cannabis trials, with a moderate-to-large effect size. The authors pointed out that positive media attention and widespread public belief in cannabis as a painkiller may be inflating expectations, which in turn boosts placebo responses in clinical trials. When the placebo group improves substantially, it becomes much harder for the active drug to show a meaningful edge.³

This does not invalidate the benefits people report from cannabis. Placebo responses involve real neurological changes, not just wishful thinking. But it does mean that a good chunk of the relief some users experience may come from their belief in the treatment rather than the drug itself. For researchers, it makes designing definitive trials particularly tricky. For you, it is worth knowing that the most carefully controlled studies tend to produce more modest results than unblinded patient surveys.

Why the Type of Product Matters

Not all cannabis products perform the same way in studies, and the differences are substantial enough to matter for anyone considering this route.

CBD alone, at least for acute pain, has not fared well. The CANBACK trial randomized emergency department patients with acute low back pain to receive either oral CBD or placebo. After two hours, pain scores were essentially identical between the two groups (about 6.2 versus 5.8 on a 10-point scale), and oxycodone use was similar. The researchers concluded CBD was not superior to placebo for acute non-traumatic low back pain.⁴

Full-spectrum cannabis products, which contain THC along with other cannabinoids and plant compounds, have produced stronger results. A phase 3 randomized trial published in Nature Medicine tested a full-spectrum cannabis extract against placebo in people with chronic low back pain. The active treatment group saw significantly greater improvements in pain, sleep quality, and physical function. Sleep quality improved by about 2.2 points in the cannabis group versus 1.5 in the placebo group. Physical function, measured by a disability questionnaire, also improved more, with roughly half of treated participants achieving at least a 30% improvement compared to about 42% on placebo. Nearly 45% of the cannabis group reported overall improvement versus about 23% on placebo.⁵

The idea that whole-plant cannabis works better than isolated cannabinoids has a name in the field: the “entourage effect.” The theory is that the various compounds in the cannabis plant work together to produce a stronger or more tolerable result than any single compound alone. A review in Pain Management noted that full-spectrum products have shown improved efficacy or tolerability compared to pure THC, though the authors stressed that definitive clinical proof of this synergy is still needed.⁶

Delivery Method and How You Take It

How you consume cannabis also appears to affect whether it helps your back. An observational study comparing sublingual (under-the-tongue) cannabis extracts to inhaled cannabis for low back pain found that pain reduction was not significant during the sublingual phase of the study but was significant during the inhaled phase.⁷

Inhaled cannabis reaches the bloodstream faster and produces more predictable peak effects than oral or sublingual routes, which are subject to wide variation in absorption. For people with chronic pain who need relatively quick relief, this difference in onset may explain why inhaled forms perform better in some studies. That said, inhaled cannabis carries its own set of concerns, particularly for lung health over time, and oral formulations allow for more precise dosing. The “best” delivery method depends on your priorities and your physician’s guidance.

The Opioid Reduction Effect

Where the cannabis-for-back-pain story gets most interesting is not in head-to-head comparisons with placebo for pain relief, but in its potential to help people reduce or stop opioid use. This finding shows up repeatedly across multiple studies and is arguably the strongest practical argument for medical cannabis in back pain management.

A study of 186 chronic back pain patients found that average daily opioid doses dropped by about 27% within six months of starting medical cannabis, and nearly 39% of patients stopped opioids entirely.⁸ A longer-term observational study found that just over half of low back pain patients were able to stop all opioid use after starting cannabis, though among those who did not stop, more than half actually increased their opioid use over time.⁹

The largest dataset on this comes from a study of 1,000 patients with chronic low back pain followed over ten years. Among those who completed the study, daily opioid equivalent doses dropped by roughly 90%, and pain scores fell by about 84%. The researchers also reported substantial reductions in the use of other medications, including benzodiazepines and antidepressants.¹⁰ A separate one-year study of medical cannabis for chronic pain more broadly reported a 20% decline in average pain intensity and a 42% reduction in daily opioid doses.¹¹

These numbers are impressive, but some caveats apply. These are mostly observational studies, meaning the patients who stick with cannabis long enough to be counted at the end may be the ones it works best for. People who did not respond or who experienced side effects may have dropped out early, inflating the apparent benefit. Still, the direction of the evidence is consistent enough to be taken seriously, especially given the well-documented risks of long-term opioid therapy.

After Spine Surgery, Cannabis Users May Actually Do Worse

If you are considering spine surgery, the relationship between cannabis and pain gets more complicated. Two studies looking at patients undergoing lumbar fusion found that cannabis users actually required more opioids after surgery than non-users. One study found significantly higher postoperative prescription opioid use among cannabis users, including among patients who had never taken opioids before surgery.¹² Another found that cannabis users had longer hospital stays (about 4.4 versus 4.0 days) and a higher rate of revision surgery (roughly 7% versus 3%).¹³

The reasons are not entirely clear, but one likely factor is tolerance. Regular cannabis use can alter how your body processes pain signals and responds to other analgesics. If you are a chronic cannabis user heading into surgery, your pain threshold and medication needs may differ from someone who is not. This is the kind of information you should share openly with your surgical team, even if it feels awkward in states where cannabis exists in a legal gray zone.

Older Adults Face Particular Risks

Back pain is extremely common in older adults, and many in this group are turning to medical cannabis. But the safety profile looks different for people over 65. A prospective study of 184 older patients (average age around 81) starting medical cannabis found that after six months, about 58% were still using it, and roughly 85% of those reported some improvement. However, about a third reported adverse effects, with dizziness and sleepiness being the most common.¹⁴

Dizziness in an 80-year-old is not the same minor nuisance it might be for a 30-year-old. Falls are a leading cause of serious injury in older adults, and a medication that causes dizziness, drowsiness, or unsteadiness raises that risk meaningfully. Cognitive impairment and agitation have also been reported in older users, particularly those with neurodegenerative conditions.¹⁵ A review in Drugs and Aging noted that almost all cannabis study participants are under 60, meaning the safety data most people rely on may not apply well to the population that most commonly deals with chronic back pain.¹⁶

Older adults also tend to take multiple medications, and cannabis can interact with several common drug classes, including blood thinners, sedatives, and certain heart medications. If you are over 65 and considering medical cannabis for back pain, the evidence suggests starting with very low doses and staying in close contact with your prescriber.

What Pain Guidelines Say

Professional guidelines have generally positioned medical cannabis as a later option, not a starting point. The European Pain Federation’s position paper states that cannabis-based medicines should only be considered after first- and second-line treatments have failed to provide sufficient relief or have been poorly tolerated. For neuropathic pain specifically, the evidence is stronger, and cannabis may be “reasonably considered.” For other chronic pain conditions, including non-specific low back pain, the Federation frames it as an individual therapeutic trial rather than a standard recommendation.¹⁷

Clinical practice guidelines published in Cannabis and Cannabinoid Research used the GRADE system to evaluate available evidence and develop recommendations for clinicians. The guidelines emphasize that cannabis should be part of a broader pain management strategy, not a standalone treatment, and that patients should have realistic expectations about the degree of relief it can provide.¹⁸

The common theme across guidelines is close monitoring. If cannabis is helping, continue under supervision. If it is not producing meaningful improvement within a defined period, stop. And if there are signs of misuse or worsening function, discontinue treatment. This sounds obvious, but cannabis occupies an unusual cultural space where many users self-medicate without medical oversight, bypassing the monitoring structure that guidelines assume.

Sleep and Quality of Life

One area where cannabis seems to deliver more consistent benefits is sleep. Poor sleep and back pain tend to reinforce each other: pain disrupts sleep, and poor sleep amplifies pain the next day. Multiple studies have shown improvements in sleep quality alongside pain reduction.

The Nature Medicine phase 3 trial found that sleep quality improved significantly more in the full-spectrum cannabis group than in the placebo group.⁵ A study of rheumatology outpatients, including those with mechanical back problems, reported an average sleep quality improvement of about 71% in that subgroup.¹⁹ Whether the sleep improvement is a direct pharmacological effect or simply a downstream consequence of having less pain is hard to disentangle, but for someone lying awake at three in the morning with a throbbing lower back, the distinction may not matter much.

Healthcare Costs and Utilization

If medical cannabis works well enough to keep some people out of emergency rooms and urgent care clinics, the economic implications are significant. A causal inference analysis of chronic pain patients found that medical cannabis users had fewer emergency department visits (a reduction of about 3 percentage points), fewer urgent care visits, and roughly 3.5 fewer unhealthy days per month compared to non-users.²⁰

On direct costs, a cost-effectiveness study comparing oral medical cannabis to opioids for chronic non-cancer pain found the two were roughly comparable. Annual per-patient costs were about $1,980 for medical cannabis versus $1,851 for opioids, a negligible difference. The quality-adjusted outcomes were virtually identical. Where the comparison tips in favor of cannabis, the authors argued, is in safety: opioid use carries a risk of fatal and nonfatal overdose that cannabis does not.²¹ A separate early economic analysis modeling various scenarios found that when cannabis-based medicines reduce pain by even a modest amount, the overall resource use decreases and the treatment becomes cost-saving compared to standard care.²²

Cost is a real consideration for many back pain patients, since chronic back pain tends to require ongoing management over years or decades. Insurance coverage for medical cannabis remains rare in most places, meaning many patients pay out of pocket. As pricing continues to fall in legal markets, the economic equation may shift further in cannabis’s favor, especially for patients who can reduce their use of other costly treatments.